期刊文献+

丹酚酸组分磷脂复合物制备研究 被引量:9

Study on preparation of salvianolic acid phospholipid compound
原文传递
导出
摘要 制备丹酚酸组分磷脂复合物,以丹酚酸组分与大豆磷脂的复合率为指标,采用单因素试验和正交试验筛选其工艺参数,结果可得丹酚酸组分磷脂复合物制备的最佳条件为以四氢呋喃为反应溶剂,反应时间3 h,反应物质量浓度5 g·L-1,药物与磷脂的反应投料质量比1∶1.5,反应温度40℃。所制备的丹酚酸组分磷脂复合物在水和不同pH缓冲液中的油水分配系数得到较大提高,DSC,XRD,FTIR等物相分析结果表明丹酚酸组分以无定形状态存在于磷脂中。 To prepare salvianolic acid phospholipid compound. With the compound of salvianolic acids and soybean phospho- lipid as the index, mono-factor experiment and orthogonal design experiment were conducted to screen its technical parameters. Ac- cording to the results, the optimal preparation conditions of salvianolic acid phospholipid compound were that THF were taken as the re- action solvent, the concentration time was 3 h, the reactant concentration was 5 g ~ L- i, the mass ratio of salvianolic acids and phos- pholipid was 1 : 1.5, and the reaction temperature was 40 ~C. The oil/water partition coefficient of the prepared salvianolic acid phos- pholipid compound significant increased in water and buffers wifll different pH values. The results of phase analysis such as DSC, XRD and FTIR indicated that salvianolic acids existed in phospholipid in an amorphous state.
出处 《中国中药杂志》 CAS CSCD 北大核心 2014年第2期216-221,共6页 China Journal of Chinese Materia Medica
基金 国家"十一五"科技支撑计划项目(2008BAI51B03) 国家中医药管理局中药口服制剂释药系统重点研究室开放基金课题(2011NDDCM01002) 江苏省中医药领军人才专项(2006)
关键词 丹酚酸组分 磷脂复合物 油水分配系数 表征 salvianolic acids phospholipid compound oil/water partition coefficient characterization
  • 相关文献

参考文献16

  • 1郁丹红,刘丹,贾晓斌,孙娥,张振海,萧伟.基于组分层次的中药多元释药系统评价体系的构建[J].中国中药杂志,2012,37(17):2667-2671. 被引量:17
  • 2刘丹,贾晓斌,郁丹红,张振海,孙娥.基于中药组分的中药多元释药系统的构建[J].中国中药杂志,2012,37(15):2338-2343. 被引量:24
  • 3徐丽君,黄光英.丹参的化学成分及其药理作用研究概述[J].中西医结合研究,2009,1(1):45-48. 被引量:88
  • 4Lai X .1, Zhang L, Li J S, et al. Comparative pharmacokinetic and bioavailability studies of three salvianolic acids after the ad- ministration of Salviae Miltiorrhizae alone or with synthetical bor- neol in rats[J]. Fitoterapia, 2011, 82(6) :883.
  • 5Rahila P, Uma B. Preparation & characterization of embelin- phospholipid complex as effective drug delivery tool [ J ]. J Incl Phenom Macrocycl Chem , 2011,69(1/2) : 139.
  • 6Tan Q Y, Liu S, Chen X L, eta|. Design and evaluation of a novel evodiamine-phosphalipid complex for improved oral bio- availability [ J ]. AAPS Pharm Sci Tech, 2012,13 ( 2 ) :534.
  • 7Devendra S, Rawat S M M, Ajay S, et al. Rutin-phospholipid complex: an innovative technique in novel drug delivery system- NDDS[J]. Curt Drug Deliv, 2012, 9(3) :305.
  • 8Cao F, Gao Y H, Yin Z, et al. Enhanced oral bioavailability of oleanolic acid in rats with phospholipid complex [ J ]. Lett Drug Des Discov, 2012, 9(5):505.
  • 9张琪,陈忻,张楠,于萍.外翻肠囊法比较黄芩苷磷脂复合物与黄芩苷在大鼠小肠的吸收[J].中国现代应用药学,2011,28(6):501-504. 被引量:9
  • 10Pathan R A, Bhandari U. Gymnemic acid-phospholipid complex : preparation and characterization [ J ]. J Dispers Sci Technol, 2011, 32(8) :1165.

二级参考文献197

共引文献304

同被引文献94

  • 1王忠壮,郑汉臣.中国楤木属一新种[J].植物资源与环境,1994,3(1):60-61. 被引量:26
  • 2郭可瑜.蒲地蓝消炎口服液治疗162例小儿急性扁桃体炎与急性咽炎的疗效[J].实用医技杂志,2006,13(9):1560-1561. 被引量:28
  • 3Rao S, Nagabhushanam M V, Chowdary K P R. In vitro dissolu- tion studies on solid dispersions of mefenamic acid [ J ]. Indian J Pharm Sci,2011,73(2) :243.
  • 4Ha J M, Kang S Y, Park C W,et al. Effect of poloxamer on physicochemical properties of tacrolimus solid dispersion impro- ving water solubility and dissolution rate [ J ]. J Pharol Invest, 2012,42(4) : 171.
  • 5Zhou Q T, Armstrong B,Larson I,et al. Understanding the influ- ence of powder flowability, fluidization and de-agglomerationcharacteristics on the aerosolization of pharmaceutical model pow- ders[J]. Eur J Pharm Sci,2010,40(5) :412.
  • 6郁丹红,刘丹,贾晓斌,等.基于生物药剂学忡质的中药组分剂型的设计技术[J].中国实验方剂学杂志,2012,37(19):2993.
  • 7Sun S P, Wei M, Olson J R, et al. Shaw biodegradable composites with aligned hydroxyapatite nanoneedles[ J]. J Biomed Mater Res B,2012,100B(7) :1817.
  • 8Pang X F, Zhou H W, Liu J L, et al. Investigation of biological property of nanohydroxyapatite materials [ J]. J Nanosci Nano- technol, 2012, 12(2) :894.
  • 9Frei B, Lawson S. Vitamin C and cancer revisited [J]. Proc Natl Acad Sci USA, 2008, 105 (32) : 11037--11038.
  • 10Welsh JL, Wagner BA, van't Erve TJ, et al. Pharmacological ascorbate with gemcitabine for the control of metastatic and node-positive pancreatic cancer (PACMAN) : results from a phase I clinical trial[J]. Cancer Chemother Pharmacol, 2013, 71 (3) : 765--775.

引证文献9

二级引证文献46

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部